510(k) K190968

CEDIA Benzodiazepine Assay by Microgenics Corporation — Product Code JXM

K190968 is an FDA 510(k) premarket notification submitted by Microgenics Corporation for the device "CEDIA Benzodiazepine Assay". The FDA issued a decision of Substantially Equivalent on Dec 9, 2019. The device falls under product code JXM (Enzyme Immunoassay, Benzodiazepine), a Class II device regulated under 21 CFR 862.3170. Microgenics Corporation has 20 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 9, 2019
Date Received
Apr 12, 2019
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Benzodiazepine
Device Class
Class II
Regulation Number
862.3170
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Microgenics Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K190968. Report a data issue: hello@regdatalab.com.